These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 24539749

  • 21. [Comments on G. Waschke's article, efficacy of vaginal smear diagnosis and colposcopy in early detection of cervical carcinoma].
    GANSE R.
    Zentralbl Gynakol; 1951; 73(13):1185-6. PubMed ID: 14867676
    [No Abstract] [Full Text] [Related]

  • 22. Coverage rate of Pap smear for cervix cancer screening during COVID-19 outbreak: Importance of continuing preventive health care.
    Mungmunpuntipantip R, Wiwanitkit V.
    J Cancer Res Ther; 2023; 19(3):847. PubMed ID: 37470628
    [No Abstract] [Full Text] [Related]

  • 23. Carcinoma of the uterine cervix and utilization of the Papanicolaou smear technique.
    Lee RE.
    Proc Inst Med Chic; 1979; 32(7):142-4, 153. PubMed ID: 392500
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
    Osamura RY.
    Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
    [Abstract] [Full Text] [Related]

  • 28. Cervical cancer and the Papanicolaou smear.
    Baird PJ.
    Aust Fam Physician; 1985 Jun; 14(6):543-4. PubMed ID: 4026707
    [No Abstract] [Full Text] [Related]

  • 29. Abnormal Pap smears, ASCUS still ob/gyn puzzle.
    Titus K.
    JAMA; 1996 Oct 02; 276(13):1014-6. PubMed ID: 8847749
    [No Abstract] [Full Text] [Related]

  • 30. Management of the patient with an abnormal Papanicolaou smear.
    Holley MR.
    Am J Obstet Gynecol; 1971 Aug 01; 110(7):976-83. PubMed ID: 5558979
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Papanicolaou smear in private practice.
    FENING W.
    Obstet Gynecol; 1957 Dec 01; 10(6):646-50. PubMed ID: 13484174
    [No Abstract] [Full Text] [Related]

  • 35. Earlier detection of recurrent cancer of the uterine cervix by vaginal smear.
    GRAHAM JB, MEIGS JV.
    Am J Obstet Gynecol; 1952 Oct 01; 64(4):908-14. PubMed ID: 12985725
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [The correlation between cytology and histopathology of primary adenocarcinoma of the uterine cervix].
    Chen SR, Chang MC, Ho WL.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 May 01; 10(5):250-5. PubMed ID: 8040928
    [Abstract] [Full Text] [Related]

  • 38. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC, Chen YY, Hsieh SF, Chiang CJ, You SL, Cheng WF, Lai MS, Chen CA, Taiwan Cervical Cancer Prevention Surveillance Center.
    Taiwan J Obstet Gynecol; 2017 Aug 01; 56(4):442-448. PubMed ID: 28805598
    [Abstract] [Full Text] [Related]

  • 39. The management of patients with a positive Papanicolaou smear.
    SWINTON NW, LEHMAN G.
    Surg Clin North Am; 1959 Jun 01; 39(3):825-30. PubMed ID: 13659397
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.